Use of Pfizer-BioNTech COVID-19 Vaccine in Persons Aged ≥16 Years: Recommendations of the Advisory Committee on Immunization Practices — United States, September 2021 | MMWR
Pfizer-biontech Covid-19 Vaccine
Is the Pfizer-BioNTech COVID vaccine still effective after 6 months?
Frontiers | COVID-19 Vaccines: Current Understanding on Immunogenicity, Safety, and Further Considerations
Comparison of Moderna versus Pfizer-BioNTech COVID-19 vaccine outcomes: A target trial emulation study in the U.S. Veterans Affairs healthcare system - eClinicalMedicine
What to know about booster shots if you received Johnson & Johnson's COVID-19 vaccine | PBS NewsHour
The U.S. COVID-19 Vaccination Program at One Year: How Many Deaths and Hospitalizations Were Averted? | Commonwealth Fund
Infections, hospitalisations, and deaths averted via a nationwide vaccination campaign using the Pfizer–BioNTech BNT162b2 mRNA COVID-19 vaccine in Israel: a retrospective surveillance study - The Lancet Infectious Diseases
Effectiveness of Pfizer-BioNTech mRNA Vaccination Against COVID-19 Hospitalization Among Persons Aged 12–18 Years — United States, June–September 2021 | MMWR
Pfizer-biontech Covid-19 Vaccine
COVID Vaccination + Booster Information | Coronavirus Information
Interim Estimates of COVID-19 Vaccine Effectiveness Against COVID-19–Associated Emergency Department or Urgent Care Clinic Encounters and Hospitalizations Among Adults During SARS-CoV-2 B.1.617.2 (Delta) Variant Predominance — Nine States, June–August ...
Vaccines and Related Biological Products Advisory Committee – 9/17/2021 - YouTube
COVID-19 tracker: Omicron booster nods expected Wednesday
Seroepidemiological study of factors affecting anti-spike IgG antibody titers after a two-dose mRNA COVID-19 vaccination in 3744 healthy Japanese volunteers | Scientific Reports
County-level vaccination coverage and rates of COVID-19 cases and deaths in the United States: An ecological analysis - The Lancet Regional Health – Americas
The Moderna vaccine makes more antibodies than Pfizer's. Does it matter? | The Japan Times
Vaccines | Free Full-Text | Evaluating COVID-19 Booster Vaccination Strategies in a Partially Vaccinated Population: A Modeling Study
Moderna Vaccine More Effective Than Pfizer, J&J, Especially After 4 Months: CDC
